# Talphera, Inc.: filings

TLPH · Nasdaq · CIK 1427925 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tlph.md) · [Financials](/companies/tlph/financials.md) · [Filings](/companies/tlph/filings.md) · [Insiders](/companies/tlph/insiders.md)

## Reports and events: 341 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 368, 8-K 229, 10-Q 47, 3 30, CORRESP 20, EFFECT 18, S-8 17, 10-K 16, 424B5 16, DEF 14A 16, UPLOAD 16, DEFA14A 15, SC 13G/A 15, S-3 14, CT ORDER 12, 425 11, SC 13G 11, D 10, 424B7 9, SC 13D/A 8, SCHEDULE 13G/A 7, 10-K/A 6, S-1/A 6, 4/A 5, 8-K/A 4, PRE 14A 4, SC 13D 4, SCHEDULE 13G 4, 144 3, 424B3 2, 424B4 2, ARS 2, S-1 2, S-3/A 2, SCHEDULE 13D/A 2, 5 1, 8-A12B 1, CERTNAS 1, POS AM 1, S-3MEF 1, S-4 1, S-4/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 16:11 ET | [10-Q](/filings/0001437749-26-027316.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027316 |
| 2026-08-12 | 16:08 ET | [8-K](/filings/0001437749-26-027311.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027311 |
| 2026-06-23 | 16:27 ET | [8-K](/filings/0001437749-26-021446.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-021446 |
| 2026-05-13 | 16:31 ET | [10-Q](/filings/0001437749-26-016748.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016748 |
| 2026-05-13 | 16:10 ET | [8-K](/filings/0001437749-26-016724.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016724 |
| 2026-04-29 | 16:31 ET | [DEF 14A](/filings/0001437749-26-013895.md) | Proxy statement, period 2026-06-22 | 0001437749-26-013895 |
| 2026-03-23 | 16:05 ET | [10-K](/filings/0001437749-26-009387.md) | Annual report, period 2025-12-31 | 0001437749-26-009387 |
| 2026-03-23 | 08:35 ET | [8-K](/filings/0001437749-26-009299.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-009299 |
| 2026-03-16 | 08:30 ET | [8-K](/filings/0001437749-26-008318.md) | 3.02 Unregistered sale of equity | 0001437749-26-008318 |
| 2026-03-13 | 16:05 ET | [8-K](/filings/0001437749-26-008217.md) | 3.01 Delisting notice | 0001437749-26-008217 |
| 2025-11-12 | 17:01 ET | [10-Q](/filings/0001437749-25-034499.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034499 |
| 2025-11-12 | 16:12 ET | [8-K](/filings/0001437749-25-034446.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034446 |
| 2025-10-24 | 16:30 ET | [8-K](/filings/0001437749-25-031731.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-031731 |
| 2025-10-22 | 08:30 ET | [8-K](/filings/0001437749-25-031468.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001437749-25-031468 |
| 2025-10-16 | 16:06 ET | [8-K](/filings/0001437749-25-031162.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-031162 |
| 2025-09-12 | 01:30 ET | [SCHEDULE 13D](/filings/0001213900-25-087369.md) | Ownership report, active investor | 0001213900-25-087369 |
| 2025-09-10 | 17:20 ET | [8-K](/filings/0001437749-25-028787.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-25-028787 |
| 2025-09-09 | 16:13 ET | [DEF 14A](/filings/0001437749-25-028683.md) | Proxy statement, period 2025-10-23 | 0001437749-25-028683 |
| 2025-08-14 | 17:02 ET | [10-Q](/filings/0001437749-25-027002.md) | Quarterly report, period 2025-06-30 | 0001437749-25-027002 |
| 2025-08-14 | 16:10 ET | [8-K](/filings/0001437749-25-026938.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026938 |
| 2025-06-05 | 17:02 ET | [8-K](/filings/0001437749-25-019574.md) | 3.01 Delisting notice | 0001437749-25-019574 |
| 2025-05-14 | 17:01 ET | [10-Q](/filings/0001437749-25-016898.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016898 |
| 2025-05-14 | 16:10 ET | [8-K](/filings/0001437749-25-016840.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016840 |
| 2025-04-29 | 16:17 ET | [10-K/A](/filings/0001437749-25-013536.md) | Annual report, amended, period 2024-12-31 | 0001437749-25-013536 |
| 2025-04-03 | 17:30 ET | [SCHEDULE 13D/A](/filings/0001104659-25-031764.md) | Ownership report, active investor, amended | 0001104659-25-031764 |
| 2025-04-02 | 21:59 ET | [SCHEDULE 13D/A](/filings/0001104659-25-031376.md) | Ownership report, active investor, amended | 0001104659-25-031376 |
| 2025-04-02 | 17:09 ET | [8-K](/filings/0001437749-25-010729.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-25-010729 |
| 2025-03-31 | 17:01 ET | [10-K](/filings/0001437749-25-010250.md) | Annual report, period 2024-12-31 | 0001437749-25-010250 |
| 2025-03-31 | 16:11 ET | [8-K](/filings/0001437749-25-010190.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-010190 |
| 2024-12-11 | 16:31 ET | [8-K](/filings/0001437749-24-037242.md) | 3.01 Delisting notice | 0001437749-24-037242 |
| 2024-11-29 | 16:30 ET | [8-K](/filings/0001437749-24-036376.md) | 3.01 Delisting notice | 0001437749-24-036376 |
| 2024-11-13 | 17:15 ET | [10-Q](/filings/0001437749-24-034965.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034965 |
| 2024-11-13 | 16:10 ET | [8-K](/filings/0001437749-24-034907.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034907 |
| 2024-10-01 | 17:29 ET | [8-K](/filings/0001437749-24-030380.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-030380 |
| 2024-08-14 | 16:12 ET | [8-K](/filings/0001437749-24-026815.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-026815 |
| 2024-08-14 | 16:10 ET | [10-Q](/filings/0001437749-24-026801.md) | Quarterly report, period 2024-06-30 | 0001437749-24-026801 |
| 2024-06-24 | 17:24 ET | [8-K](/filings/0001437749-24-021108.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-021108 |
| 2024-05-14 | 17:00 ET | [10-Q](/filings/0001437749-24-016694.md) | Quarterly report, period 2024-03-31 | 0001437749-24-016694 |
| 2024-05-14 | 16:15 ET | [8-K](/filings/0001437749-24-016626.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-016626 |
| 2024-04-29 | 16:23 ET | [DEF 14A](/filings/0001437749-24-013703.md) | Proxy statement, period 2024-06-24 | 0001437749-24-013703 |
| 2024-04-19 | 16:37 ET | [8-K](/filings/0001437749-24-012568.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001437749-24-012568 |
| 2024-03-06 | 17:00 ET | [10-K](/filings/0001437749-24-006849.md) | Annual report, period 2023-12-31 | 0001437749-24-006849 |
| 2024-03-06 | 16:11 ET | [8-K](/filings/0001437749-24-006817.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-006817 |
| 2024-03-01 | 07:35 ET | [8-K](/filings/0001437749-24-006219.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-006219 |
| 2024-01-23 | 18:46 ET | [SC 13D](/filings/0001104659-24-005645.md) | Ownership report, active investor | 0001104659-24-005645 |
| 2024-01-22 | 17:12 ET | [8-K](/filings/0001437749-24-001879.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001879 |
| 2024-01-18 | 08:35 ET | [8-K](/filings/0001437749-24-001579.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-001579 |
| 2024-01-09 | 09:17 ET | [8-K](/filings/0001437749-24-000938.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-000938 |
| 2023-11-14 | 06:07 ET | [10-Q](/filings/0001437749-23-031742.md) | Quarterly report, period 2023-09-30 | 0001437749-23-031742 |
| 2023-11-08 | 16:14 ET | [8-K](/filings/0001437749-23-030955.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-030955 |

Page 1 of 7. [Older](/companies/tlph/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.